Brandon Allgood, Numerate

Brandon Allgood Brandon Allgood is the CTO and cofounder at Numerate, Inc, an AI driven drug discovery company. Brandon leads research and development of Numerate’s AI platform. He also leads the data science group, is the primary technical lead on both internal and collaborative drug discovery programs and is responsible for the technology vision at Numerate. Brandon has previously served as Director of Computational Science at Numerate and as a Research Scientist at Pharmix. He received a B.S. in Physics from the University of Washington, Seattle, and a Ph.D. in Computational Physics from the University of California, Santa Cruz. Brandon has authored scientific publications in astrophysics, solid-state physics, and computational chemistry and biology and has 15 years of experience in AI, mathematical modeling, and large scale cloud and distributed computing. He advises a number of venture capital firms and start-up companies, is a founder of the Alliance for AI in Healthcare, a member of the Forbes Technology Council and a UCSC Foundation Trustee.


11:50 AM - 12:15 PM

Employing AI to find the Translational Piece for Making Drugs Effective, Validated and Useful in Humans

Gini Deshpande, CEO, NuMedii

Case Study: Achieving Higher Success Rates of Translation from Biology to Pre-Clinical, and from Pre-Clinical to Clinical Programs
Brandon Allgood, CTO and Co-Founder, Numerate

Download Latest Agenda